Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Freytag

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Schmerz (Berlin, Germany)|March 23, 2011
[Opioid therapy in patients with back pain. Claims data analysis for patient group characterization, influence on opioid therapy and work disability]A Höer, A Freytag, G Schiffhorst, et al.
Arzneimittel-Forschung|January 1, 1985
[Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets]H W von Schrader, G Buscher, D Dierdorf, et al.
Medical Microbiology and Immunology|January 1, 1984
A virus antigen (HBsAg) indicates metastases of human carcinoma cells in the nude mouseO Marquardt, A Freytag von Loringhoven, R Koshy, et al.
Journal of Medical Economics|October 14, 2011
Healthcare utilization of back pain patients: results of a claims data analysisG Müller-Schwefe, A Freytag, A Höer, et al.
Gastroenterology|May 1, 1997
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapyG Sauter, G A Kullak-Ublick, R Schumacher, et al.
BMC Palliative Care|August 5, 2020
Factors influencing GPs' perception of specialised palliative homecare (SPHC) importance - results of a cross-sectional studyK Stichling, M Krause, B Ditscheid, et al.
Schmerz (Berlin, Germany)|January 19, 2010
[Identification and grouping of pain patients according to claims data]A Freytag, G Schiffhorst, R Thoma, et al.
Schmerz (Berlin, Germany)|April 11, 2014
[Use and potential risks of over-the-counter analgesics]A Freytag, R Quinzler, M Freitag, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Schmerz (Berlin, Germany)|March 23, 2011
[Opioid therapy in patients with back pain. Claims data analysis for patient group characterization, influence on opioid therapy and work disability]A Höer, A Freytag, G Schiffhorst, et al.
Arzneimittel-Forschung|January 1, 1985
[Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets]H W von Schrader, G Buscher, D Dierdorf, et al.
Medical Microbiology and Immunology|January 1, 1984
A virus antigen (HBsAg) indicates metastases of human carcinoma cells in the nude mouseO Marquardt, A Freytag von Loringhoven, R Koshy, et al.
Journal of Medical Economics|October 14, 2011
Healthcare utilization of back pain patients: results of a claims data analysisG Müller-Schwefe, A Freytag, A Höer, et al.
Gastroenterology|May 1, 1997
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapyG Sauter, G A Kullak-Ublick, R Schumacher, et al.
BMC Palliative Care|August 5, 2020
Factors influencing GPs' perception of specialised palliative homecare (SPHC) importance - results of a cross-sectional studyK Stichling, M Krause, B Ditscheid, et al.
Schmerz (Berlin, Germany)|January 19, 2010
[Identification and grouping of pain patients according to claims data]A Freytag, G Schiffhorst, R Thoma, et al.
Schmerz (Berlin, Germany)|April 11, 2014
[Use and potential risks of over-the-counter analgesics]A Freytag, R Quinzler, M Freitag, et al.
Pageof 2